ArticleJournal for immunotherapy of cancer2025
SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development.
Leisha A Emens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it